Table 2

Follow-up and AF detection in randomised controlled studies in the meta-analysis

Author (study) year (ref no)Follow-up periodDefinition of AFMethods of AF detectionRate of AF in control groupPowerδ (% risk reduction)
Calo et al 200520During hospitalisationPostoperative inhospital AF >5 min or requiring interventionContinuous monitoring at least 4–5 days after the operation; ECG daily until discharge; AF endpoint adjudicated by a blinded external committee33.3%0.843
Erdogan et al 2007* 2452 WeeksRecurrent AFClinical examination with ECG after 4 weeks, 12 weeks and 1 year or at any point of occurrence of symptoms85.2%0.815
Margos et al 2007* 276 MonthsRecurrent AF24 h Holter at 1 month, ECG at 1, 3 and 6 months40%NANA
Heidt et al 200921During ICUPostoperative inhospital AF ≥15 minContinuous monitoring and ECG daily until transfer from the ICU to a normal ward30%0.833
Heidarsdottir et al 201022During hospitalisationPostoperative inhospital AF ≥5 minContinuous monitoring until discharge54.1%0.850
Saravanan et al 2010235 DaysPostoperative inhospital AF ≥30 sContinuous monitoring at least 5 days after the operation; then ECG daily until discharge; AF endpoint adjudicated by a blinded external committee43.1%0.855
Sandesara et al 2010* 2614 DaysPostoperative clinically significant AF or atrial flutter documented by rhythm strip or ECG and requiring treatmentContinuous monitoring and ECG; AF endpoint adjudicated by a blinded external committee33%0.954
Bianconi et al 2010256 MonthsRecurrent AF
  • Trans-telephonic monitoring three times during first week and then twice a week until the 3 month follow-up and ECG at 48–72 h, 1 week and 1, 3 and 6 months

  • AF endpoint adjudicated by the blinded investigators

51.1%0.830
Nodari et al 2010* 281 YearRecurrent AFECG and 24-h Holter at 1, 3, 6 and 12 months63%NANA
Kowey et al 2010296 MonthsRecurrent AFTrans-telephonic monitoring every 2 weeks; AF endpoint adjudicated by the blinded investigators46%0.932
  • * Abstract only.

  • AF, atrial fibrillation; ICU, intensive care unit; δ, the minimum detectable difference the study was powered to detect.